nutrigenomics

(redirected from nutragenomics)
Also found in: Dictionary.

nutrigenomics

(no͞o′trə-jə-nō′mĭks, nyo͞o′-)
n. (used with a sing. verb)
The study of how the genome and diet interact to influence human and animal health and disease.

nu·tri·ge·no·mics

(nū'tri-jē-nō'miks)
The study of how diet influences gene expression, and thus, health.
Synonym(s): nutragenomics, nutritional genomics.
[nutri- + genomics]

nutrigenomics

The use of knowledge of an individual's genetic makeup to devise a personally appropriate eating strategy. Also known as “personalized nutrition.”

nutrigenomics

analysis of the effects of nutrient intake on gene function and health, by using such approaches as GENOMICS, METABOLOMICS, PROTEOMICS and TRANSCRIPTOMICS. Genetic variations affect how the body utilizes nutrients and removes toxins. An understanding of an individual's genotype should enable diets to be tailored to meet specific genetic needs and new foods developed for personalized health and nutritional benefit.
References in periodicals archive ?
Number of newspaper articles on nutrigenomics that refer to a nutrigenomics company Nutrigenomics Company Number of Newspaper Articles Genelex 29 Sciona 17 Consumer Genetics 14 NutraGenomics 11 One Person Health 8 Healthcheck USA 7 Genecare 5 Alphagenics 5 WellGen 3 DNA Diet 2 Metagenics 2 Suracell 1 Nutrigen 0 Salugen 0
Their CellF diagnostic panel represents the first large scale entry into the field of nutragenomics.
a biotechnology company using nutragenomics to develop wellness products from plants that alter the expression of genes responsible for human disease, announced today that it has received $3 million in the form of equity capital, through a private offering of preferred stock, from venture-capital investors led by Amphion Capital Partners LLC.
New Brunswick, NJ, a biotechnology company using nutragenomics to develop wellness products from plants that alter the expression of genes responsible for human disease, has received $3 million in the form of equity capital, through a private offering of preferred stock, from venture-capital investors led by Amphion Capital Partners LLC, New York, NY.
This session will discuss nutragenomics and how it will create an intensely competitive new environment for business in the future.
Increased consumer awareness, changes in our healthcare paradigm and technology advances such as nutragenomics will make major impacts on the future of this industry.